(ii) Antiangiogenic, fascaplysin inhibits the expression and excretion of vascular endothelial growth factor (VEGF), and destroys angiogenesis to achieve anti-tumor effect [26,27]; and (iii) the consecutive induction of apoptosis [28,29,30,31].. Here, VEGFA is linked to neoplasm.